Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
|
| |
(Mark One) | |
x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended February 28, 2019
OR
|
| |
o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number 1-10658
Micron Technology, Inc.
(Exact name of registrant as specified in its charter)
|
| |
Delaware | 75-1618004 |
(State or other jurisdiction of | (IRS Employer Identification No.) |
incorporation or organization) | |
| |
8000 S. Federal Way, Boise, Idaho | 83716-9632 |
(Address of principal executive offices) | (Zip Code) |
| |
Registrant's telephone number, including area code | (208) 368-4000 |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes T No ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes T No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
|
| | | | |
Large Accelerated Filer x | Accelerated Filer o | Non-Accelerated Filer o | Smaller Reporting Company o | Emerging Growth Company o |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x
The number of outstanding shares of the registrant's common stock as of March 14, 2019 was 1,106,687,011.
Micron Technology, Inc., including its consolidated subsidiaries, is an industry leader in innovative memory and storage solutions. Through our global brands – Micron®, Crucial®, and Ballistix® – our broad portfolio of high-performance memory and storage technologies, including DRAM, NAND, NOR Flash, and 3D XPoint memory, is transforming how the world uses information to enrich life. Backed by 40 years of technology leadership, our memory and storage solutions enable disruptive trends, including artificial intelligence, machine learning, and autonomous vehicles, in key market segments like data center, networking, automotive, industrial, mobile, graphics, and client.
Micron, Crucial, Ballistix, any associated logos, and all other Micron trademarks are the property of Micron. 3D XPoint is a trademark of Intel in the United States and/or other countries. Other product names or trademarks that are not owned by Micron are for identification purposes only and may be the registered or unregistered trademarks of their respective owners.
Definitions of Commonly Used Terms
As used herein, "we," "our," "us," and similar terms include Micron Technology, Inc. and our consolidated subsidiaries, unless the context indicates otherwise. Abbreviations, terms, or acronyms are commonly used or found in multiple locations throughout this report and include the following:
|
| | | | | | |
Term | | Definition | | Term | | Definition |
2022 Term Loan B | | Senior Secured Term Loan B due 2022 | | Micron | | Micron Technology, Inc. (Parent Company) |
2024 Notes | | 4.64% Senior Unsecured Notes due 2024 | | MMJ | | Micron Memory Japan, G.K. |
2025 Notes | | 5.50% Senior Unsecured Notes due 2025 | | MMJ Group | | MMJ and its subsidiaries |
2026 Notes | | 4.98% Senior Unsecured Notes due 2026 | | MMT | | Micron Memory Taiwan Co., Ltd. |
2029 Notes | | 5.33% Senior Unsecured Notes due 2029 | | MTTW | | Micron Technology Taiwan, Inc. |
2032D Notes | | 3.13% Convertible Senior Notes due 2032 | | Qimonda | | Qimonda AG |
2033F Notes | | 2.13% Convertible Senior Notes due 2033 | | R&D | | Research and Development |
2043G Notes | | 3.00% Convertible Senior Notes due 2043 | | SG&A | | Selling, General, and Administrative |
CPU | | Central Processing Unit | | SSD | | Solid-State Drive |
IMFT | | IM Flash Technologies, LLC | | TLC | | Triple-Level Cell |
Inotera | | Inotera Memories, Inc. | | VIE | | Variable Interest Entity |
Intel | | Intel Corporation | | | | |
The following Micron subsidiaries appear throughout this report:
|
| | |
Micron Consumer Products Group, Inc. | | Micron Semiconductor Products, Inc. |
Micron Europe Limited | | Micron Semiconductor (Shanghai) Co. Ltd. |
Micron Semiconductor B.V., | | Micron Semiconductor (Xi’an) Co., Ltd. |
Micron Semiconductor (Deutschland) GmbH | | |
Forward-Looking Statements
This Form 10-Q contains trend information and other forward-looking statements that involve a number of risks and uncertainties. Forward-looking statements include, but are not limited to, statements such as those made regarding our expected NAND and 3D XPointTM development activities with Intel; the amount we expect to pay to purchase Intel's interest in IMFT; our expectation, from time to time, to engage in additional financing transactions; the sufficiency of our cash and investments, cash flows from operations, and available financing to meet our requirements at least through the next 12 months; and capital spending in 2019. We are under no obligation to update these forward-looking statements. Our actual results could differ materially from our historical results and those discussed in the forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, those identified in "Part II, Other Information – Item 1A. Risk Factors."
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
MICRON TECHNOLOGY, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(in millions except per share amounts)
(Unaudited)
|
| | | | | | | | | | | | | | | |
| Quarter ended | | Six months ended |
| February 28, 2019 | | March 1, 2018 | | February 28, 2019 | | March 1, 2018 |
Revenue | $ | 5,835 |
| | $ | 7,351 |
| | $ | 13,748 |
| | $ | 14,154 |
|
Cost of goods sold | 2,971 |
| | 3,081 |
| | 6,269 |
| | 6,137 |
|
Gross margin | 2,864 |
| | 4,270 |
| | 7,479 |
| | 8,017 |
|
| | | | | | | |
Selling, general, and administrative | 209 |
| | 196 |
| | 418 |
| | 387 |
|
Research and development | 601 |
| | 523 |
| | 1,212 |
| | 971 |
|
Other operating (income) expense, net | 97 |
| | (16 | ) | | 133 |
| | (5 | ) |
Operating income | 1,957 |
| | 3,567 |
| | 5,716 |
| | 6,664 |
|
| | | | | | | |
Interest income | 58 |
| | 27 |
| | 96 |
| | 50 |
|
Interest expense | (27 | ) | | (88 | ) | | (60 | ) | | (212 | ) |
Other non-operating income (expense), net | (84 | ) | | (53 | ) | | (75 | ) | | (257 | ) |
| 1,904 |
| | 3,453 |
| | 5,677 |
| | 6,245 |
|
| | | | | | | |
Income tax provision | (280 | ) | | (143 | ) | | (757 | ) | | (257 | ) |
Equity in net income of equity method investees | 1 |
| | 1 |
| | 1 |
| | 1 |
|
Net income | 1,625 |
| | 3,311 |
| | 4,921 |
| | 5,989 |
|
| | | | | | | |
Net income attributable to noncontrolling interests | (6 | ) | | (2 | ) | | (9 | ) | | (2 | ) |
Net income attributable to Micron | $ | 1,619 |
| | $ | 3,309 |
| | $ | 4,912 |
| | $ | 5,987 |
|
| | | | | | | |
Earnings per share | | | | | | | |
Basic | $ | 1.45 |
| | $ | 2.86 |
| | $ | 4.37 |
| | $ | 5.23 |
|
Diluted | 1.42 |
| | 2.67 |
| | 4.24 |
| | 4.86 |
|
| | | | | | | |
Number of shares used in per share calculations | | | | | | | |
Basic | 1,114 |
| | 1,156 |
| | 1,123 |
| | 1,145 |
|
Diluted | 1,141 |
| | 1,238 |
| | 1,157 |
| | 1,232 |
|
See accompanying notes to consolidated financial statements.
MICRON TECHNOLOGY, INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(in millions)
(Unaudited)
|
| | | | | | | | | | | | | | | |
| Quarter ended | | Six months ended |
| February 28, 2019 | | March 1, 2018 | | February 28, 2019 | | March 1, 2018 |
Net income | $ | 1,625 |
| | $ | 3,311 |
| | $ | 4,921 |
| | $ | 5,989 |
|
| | | | | | | |
Other comprehensive income (loss), net of tax | | | | | | | |
Gains (losses) on derivative instruments | 6 |
| | 18 |
| | (6 | ) | | 15 |
|
Unrealized gains (losses) on investments | 6 |
| | (1 | ) | | 3 |
| | (2 | ) |
Foreign currency translation adjustments | (1 | ) | | — |
| | (1 | ) | | — |
|
Pension liability adjustments | — |
| | 2 |
| | — |
| | 1 |
|
Other comprehensive income (loss) | 11 |
| | 19 |
| | (4 | ) | | 14 |
|
Total comprehensive income | 1,636 |
| | 3,330 |
| | 4,917 |
| | 6,003 |
|
Comprehensive income attributable to noncontrolling interests | (6 | ) | | (2 | ) | | (9 | ) | | (2 | ) |
Comprehensive income attributable to Micron | $ | 1,630 |
| | $ | 3,328 |
| | $ | 4,908 |
| | $ | 6,001 |
|
See accompanying notes to consolidated financial statements.
MICRON TECHNOLOGY, INC.
CONSOLIDATED BALANCE SHEETS
(in millions except par value amounts)
(Unaudited)
|
| | | | | | | | |
As of | | February 28, 2019 | | August 30, 2018 |
Assets | | | | |
Cash and equivalents | | $ | 6,353 |
| | $ | 6,506 |
|
Short-term investments | | 1,180 |
| | 296 |
|
Receivables | | 4,416 |
| | 5,478 |
|
Inventories | | 4,390 |
| | 3,595 |
|
Other current assets | | 211 |
| | 164 |
|
Total current assets | | 16,550 |
| | 16,039 |
|
Long-term marketable investments | | 1,614 |
| | 473 |
|
Property, plant, and equipment | | 26,204 |
| | 23,672 |
|
Intangible assets | | 350 |
| | 331 |
|
Deferred tax assets | | 762 |
| | 1,022 |
|
Goodwill | | 1,228 |
| | 1,228 |
|
Other noncurrent assets | | 779 |
| | 611 |
|
Total assets | | $ | 47,487 |
| | $ | 43,376 |
|
| | | | |
Liabilities and equity | | | | |
Accounts payable and accrued expenses | | $ | 4,062 |
| | $ | 4,374 |
|
Current debt | | 2,634 |
| | 859 |
|
Other current liabilities | | 665 |
| | 521 |
|
Total current liabilities | | 7,361 |
| | 5,754 |
|
Long-term debt | | 3,604 |
| | 3,777 |
|
Other noncurrent liabilities | | 993 |
| | 581 |
|
Total liabilities | | 11,958 |
| | 10,112 |
|
| | | | |
Commitments and contingencies | |
|
| |
|
|
| | | | |
Redeemable convertible notes | | 2 |
| | 3 |
|
Redeemable noncontrolling interest | | 97 |
| | 97 |
|
| | | | |
Micron shareholders' equity | | | | |
Common stock, $0.10 par value, 3,000 shares authorized, 1,178 shares issued and 1,106 outstanding (1,170 shares issued and 1,161 outstanding as of August 30, 2018) | 118 |
| | 117 |
|
Additional capital | | 8,143 |
| | 8,201 |
|
Retained earnings | | 29,364 |
| | 24,395 |
|
Treasury stock, 72 shares held (9 shares as of August 30, 2018) | | (3,064 | ) | | (429 | ) |
Accumulated other comprehensive income | | 6 |
| | 10 |
|
Total Micron shareholders' equity | | 34,567 |
| | 32,294 |
|
Noncontrolling interests in subsidiaries | | 863 |
| | 870 |
|
Total equity | | 35,430 |
| | 33,164 |
|
Total liabilities and equity | | $ | 47,487 |
| | $ | 43,376 |
|
See accompanying notes to consolidated financial statements.
MICRON TECHNOLOGY, INC.
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
(in millions)
(Unaudited)
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Micron Shareholders | | | | |
| | Common Stock | | Additional Capital | | Retained Earnings | | Treasury Stock | | Accumulated Other Comprehensive Income (Loss) | | Total Micron Shareholders' Equity | | Noncontrolling Interests in Subsidiaries | | Total Equity |
| | Number of Shares | | Amount | | | | | | | |
Balance at August 30, 2018 | | 1,170 |
| | $ | 117 |
| | $ | 8,201 |
| | $ | 24,395 |
| | $ | (429 | ) | | $ | 10 |
| | $ | 32,294 |
| | $ | 870 |
| | $ | 33,164 |
|
Cumulative effect of adopting new accounting standards | | | | | | | | 92 |
| | | | | | 92 |
| | | | 92 |
|
Net income | | | | | | | | 3,293 |
| | | | | | 3,293 |
| | — |
| | 3,293 |
|
Other comprehensive income (loss), net | | | | | | | | | | | | (15 | ) | | (15 | ) | | | | (15 | ) |
Stock issued under stock plans | | 3 |
| | — |
| | 15 |
| | | | | | | | 15 |
| | | | 15 |
|
Stock-based compensation expense | | | | | | 61 |
| | | | | | | | 61 |
| | | | 61 |
|
Repurchase of stock | | (1 | ) | | — |
| | 108 |
| | (11 | ) | | (1,933 | ) | | | | (1,836 | ) | | | | (1,836 | ) |
Reclassification of redeemable convertible notes, net | | | | | | 1 |
| | | | | | | | 1 |
| | | | 1 |
|
Conversion and repurchase of convertible notes | | | | | | (36 | ) | | | | | | | | (36 | ) | | | | (36 | ) |
Balance at November 29, 2018 | | 1,172 |
| | $ | 117 |
| | $ | 8,350 |
| | $ | 27,769 |
| | $ | (2,362 | ) | | $ | (5 | ) | | $ | 33,869 |
| | $ | 870 |
| | $ | 34,739 |
|
Net income | | | | | | | | 1,619 |
| | | | | | 1,619 |
| | 5 |
| | 1,624 |
|
Other comprehensive income (loss), net | | | | | | | | | | | | 11 |
| | 11 |
| | | | 11 |
|
Stock issued under stock plans | | 7 |
| | 1 |
| | 76 |
| | | | | | | | 77 |
| | | | 77 |
|
Stock-based compensation expense | | | | | | 57 |
| | | | | | | | 57 |
| | | | 57 |
|
Repurchase of stock | | (1 | ) | | — |
| | (5 | ) | | (24 | ) | | (702 | ) | | | | (731 | ) | | | | (731 | ) |
Acquisitions of noncontrolling interest | | | | | | | | | | | | | | — |
| | (12 | ) | | (12 | ) |
Reclassification of redeemable convertible notes, net | | | | | | 1 |
| | | | | | | | 1 |
| | | | 1 |
|
Conversion and repurchase of convertible notes | | | | | | (336 | ) | | | | | | | | (336 | ) | | | | (336 | ) |
Balance at February 28, 2019 | | 1,178 |
| | $ | 118 |
| | $ | 8,143 |
| | $ | 29,364 |
| | $ | (3,064 | ) | | $ | 6 |
| | $ | 34,567 |
| | $ | 863 |
| | $ | 35,430 |
|
See accompanying notes to consolidated financial statements.
MICRON TECHNOLOGY, INC.
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
(in millions)
(Unaudited)
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Micron Shareholders | | | | |
| | Common Stock | | Additional Capital | | Retained Earnings | | Treasury Stock | | Accumulated Other Comprehensive Income (Loss) | | Total Micron Shareholders' Equity | | Noncontrolling Interests in Subsidiaries | | Total Equity |
| | Number of Shares | | Amount | | | | | | | |
Balance at August 31, 2017 | | 1,116 |
| | $ | 112 |
| | $ | 8,287 |
| | $ | 10,260 |
| | $ | (67 | ) | | $ | 29 |
| | $ | 18,621 |
| | $ | 849 |
| | $ | 19,470 |
|
Net income | | | | | | | | 2,678 |
| | | | | | 2,678 |
| | — |
| | 2,678 |
|
Other comprehensive income (loss), net | | | | | | | | | | | | (5 | ) | | (5 | ) | | | | (5 | ) |
Contributions from noncontrolling interests | | | | | | | | | | | | | | | | 18 |
| | 18 |
|
Stock issued in public offering | | 34 |
| | 3 |
| | 1,363 |
| | | | | | | | 1,366 |
| | | | 1,366 |
|
Stock issued under stock plans | | 9 |
| | 1 |
| | 105 |
| | | | | | | | 106 |
| | | | 106 |
|
Stock-based compensation expense | | | | | | 51 |
| | | | | | | | 51 |
| | | | 51 |
|
Repurchase of stock | | (1 | ) | | — |
| | (90 | ) | | | | — |
| | | | (90 | ) | | | | (90 | ) |
Reclassification of redeemable convertible notes, net | | | | | | 3 |
| | | | | | | | 3 |
| | | | 3 |
|
Conversion and repurchase of convertible notes | | | | | | (271 | ) | | | | 67 |
| | | | (204 | ) | | | | (204 | ) |
Balance at November 30, 2017 | | 1,158 |
| | $ | 116 |
| | $ | 9,448 |
| | $ | 12,938 |
| | $ | — |
| | $ | 24 |
| | $ | 22,526 |
| | $ | 867 |
| | $ | 23,393 |
|
Net income | | | | | | | | 3,309 |
| | | | | | 3,309 |
| | 2 |
| | 3,311 |
|
Other comprehensive income (loss), net | | | | | | | | | | | | 19 |
| | 19 |
| | | | 19 |
|
Stock issued under stock plans | | 8 |
| | — |
| | 82 |
| | | | | | | | 82 |
| | | | 82 |
|
Stock-based compensation expense | | | | | | 52 |
| | | | | | | | 52 |
| | | | 52 |
|
Repurchase of stock | | (1 | ) | | — |
| | (44 | ) | | | | — |
| | | | (44 | ) | | | | (44 | ) |
Settlement of capped calls | | | | | | 313 |
| | | | (313 | ) | | | | — |
| | | | — |
|
Reclassification of redeemable convertible notes, net | | | | | | 5 |
| | | | | | | | 5 |
| | | | 5 |
|
Conversion and repurchase of convertible notes | | | | | | (252 | ) | | | | | | | | (252 | ) | | | | (252 | ) |
Balance at March 1, 2018 | | 1,165 |
| | $ | 116 |
| | $ | 9,604 |
| | $ | 16,247 |
| | $ | (313 | ) | | $ | 43 |
| | $ | 25,697 |
| | $ | 869 |
| | $ | 26,566 |
|
See accompanying notes to consolidated financial statements.
MICRON TECHNOLOGY, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in millions)
(Unaudited)
|
| | | | | | | | |
Six months ended | | February 28, 2019 | | March 1, 2018 |
Cash flows from operating activities | | | | |
Net income | | $ | 4,921 |
| | $ | 5,989 |
|
Adjustments to reconcile net income to net cash provided by operating activities | | |
| | |
|
Depreciation expense and amortization of intangible assets | | 2,648 |
| | 2,241 |
|
Amortization of debt discount and other costs | | 29 |
| | 55 |
|
Stock-based compensation | | 118 |
| | 103 |
|
Loss on debt prepayments, repurchases, and conversions | | 69 |
| | 218 |
|
Change in operating assets and liabilities | | |
| | |
|
Receivables | | 1,202 |
| | (630 | ) |
Inventories | | (800 | ) | | (62 | ) |
Deferred tax assets | | 320 |
| | (262 | ) |
Accounts payable and accrued expenses | | (326 | ) | | 178 |
|
Other | | 64 |
| | 154 |
|
Net cash provided by operating activities | | 8,245 |
| | 7,984 |
|
| | | | |
Cash flows from investing activities | | |
| | |
|
Expenditures for property, plant, and equipment | | (5,349 | ) | | (4,217 | ) |
Purchases of available-for-sale securities | | (2,566 | ) | | (502 | ) |
Proceeds from government incentives | | 455 |
| | 1 |
|
Proceeds from maturities of available-for-sale securities | | 391 |
| | 138 |
|
Proceeds from sales of available-for-sale securities | | 160 |
| | 562 |
|
Other | | (10 | ) | | 175 |
|
Net cash provided by (used for) investing activities | | (6,919 | ) | | (3,843 | ) |
| | | | |
Cash flows from financing activities | | |
| | |
|
Payments to acquire treasury stock | | (2,568 | ) | | (67 | ) |
Repayments of debt | | (705 | ) | | (3,379 | ) |
Payments on equipment purchase contracts | | (37 | ) | | (153 | ) |
Proceeds from issuance of debt | | 1,800 |
| | 650 |
|
Proceeds from issuance of stock | | 92 |
| | 1,554 |
|
Other | | (65 | ) | | (25 | ) |
Net cash provided by (used for) financing activities | | (1,483 | ) | | (1,420 | ) |
| | | | |
Effect of changes in currency exchange rates on cash, cash equivalents, and restricted cash | | (1 | ) | | 4 |
|
| | | | |
Net increase (decrease) in cash, cash equivalents, and restricted cash | | (158 | ) | | 2,725 |
|
Cash, cash equivalents, and restricted cash at beginning of period | | 6,587 |
| | 5,216 |
|
Cash, cash equivalents, and restricted cash at end of period | | $ | 6,429 |
| | $ | 7,941 |
|
See accompanying notes to consolidated financial statements.
MICRON TECHNOLOGY, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(All tabular amounts in millions except per share amounts)
(Unaudited)
Basis of Presentation
The accompanying consolidated financial statements include the accounts of Micron and our consolidated subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America consistent in all material respects with those applied in our Annual Report on Form 10-K for the year ended August 30, 2018, except for changes related to recently adopted accounting standards. See "Recently Adopted Accounting Standards" note. Prior year information is presented in accordance with the accounting guidance in effect during that period and has not been recast for recently adopted accounting standards. In the opinion of our management, the accompanying unaudited consolidated financial statements contain all necessary adjustments, consisting of a normal recurring nature, to fairly state the financial information set forth herein. Certain reclassifications have been made to prior period amounts to conform to current period presentation.
Our fiscal year is the 52 or 53-week period ending on the Thursday closest to August 31. Fiscal years 2019 and 2018 each contain 52 weeks. All period references are to our fiscal periods unless otherwise indicated. These interim financial statements should be read in conjunction with the consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for the year ended August 30, 2018.
Variable Interest Entities
We have interests in entities that are VIEs. If we are the primary beneficiary of a VIE, we are required to consolidate it. To determine if we are the primary beneficiary, we evaluate whether we have the power to direct the activities that most significantly impact the VIE's economic performance and the obligation to absorb losses or the right to receive benefits of the VIE that could potentially be significant to the VIE. Our evaluation includes identification of significant activities and an assessment of our ability to direct those activities based on governance provisions and arrangements to provide or receive product and process technology, product supply, operations services, equity funding, financing, and other applicable agreements and circumstances. Our assessments of whether we are the primary beneficiary of our VIEs require significant assumptions and judgments.
Unconsolidated VIEs
PTI Xi'an: Powertech Technology Inc. Xi'an ("PTI Xi'an") is a wholly-owned subsidiary of Powertech Technology Inc. ("PTI") and was created to provide assembly services to us at our manufacturing site in Xi'an, China. We do not have an equity interest in PTI Xi'an. PTI Xi'an is a VIE because of the terms of its service agreement with us and its dependency on PTI to finance its operations. We do not have the power to direct the activities of PTI Xi'an that most significantly impact its economic performance, primarily because we do not have governance rights. Therefore, we do not consolidate PTI Xi'an. In connection with our assembly services with PTI, as of February 28, 2019 and August 30, 2018, we had net property, plant, and equipment of $56 million and $63 million, respectively, and capital lease obligations of $55 million and $63 million, respectively.
Consolidated VIE
IMFT: IMFT is a VIE because all of its costs are passed to us and its other member, Intel, through product purchase agreements and because IMFT is dependent upon us or Intel for additional cash requirements. The primary activities of IMFT are driven by the constant introduction of product and process technology. Because we perform a significant majority of the technology development, we have the power to direct its key activities. We consolidate IMFT because we have the power to direct the activities of IMFT that most significantly impact its economic performance and because we have the obligation to absorb losses and the right to receive benefits from IMFT that could potentially be significant to it. On January 14, 2019, we exercised our option to acquire Intel's interest in IMFT. As a result, Intel can elect to set the closing date of the transaction to be any time between approximately six months to one year from the date we exercised our call option. (See "Equity – Noncontrolling Interests in Subsidiaries – IMFT" note.)
Recently Adopted Accounting Standards
In October 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2016-16 – Intra-Entity Transfers Other Than Inventory ("ASU 2016-16"), which requires an entity to recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs. We adopted this ASU in the first quarter of 2019 under the modified retrospective method and, in connection therewith, made certain adjustments as noted in the table below.
In January 2016, the FASB issued ASU 2016-01 – Recognition and Measurement of Financial Assets and Financial Liabilities, which provides guidance for the recognition, measurement, presentation, and disclosure of financial assets and liabilities. We adopted this ASU in the first quarter of 2019 under the modified retrospective method, with prospective adoption for amendments related to equity securities without readily determinable fair values. The adoption of this ASU did not have a material impact on our financial statements.
In May 2014, the FASB issued ASU 2014-09 – Revenue from Contracts with Customers (as amended, "ASC 606"), which supersedes nearly all existing revenue recognition guidance under generally accepted accounting principles in the United States. The core principal of ASC 606 is that an entity should recognize revenue when it transfers control of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASC 606 also requires additional disclosure about the nature, amount, timing, and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments, and assets recognized from costs incurred to obtain or fulfill a contract. We adopted ASC 606 in the first quarter of 2019 under the modified retrospective method and, in connection therewith, made certain adjustments as noted in the table below. We applied ASC 606 to contracts with customers that had not yet been completed as of the adoption date.
The following table summarizes the effects of adopting ASU 2016-16 and ASC 606.
|
| | | | | | | | | | | | | | | |
| | | | | | | |
| Ending Balance as of August 30, 2018 | | ASU 2016-16 | | ASC 606 | | Opening Balance as of August 31, 2018 |
Receivables | $ | 5,478 |
| | $ | — |
| | $ | 114 |
| | $ | 5,592 |
|
Inventories | 3,595 |
| | — |
| | (5 | ) | | 3,590 |
|
Other current assets | 164 |
| | (14 | ) | | 30 |
| | 180 |
|
Deferred tax assets | 1,022 |
| | 56 |
| | (92 | ) | | 986 |
|
Other current liabilities | 521 |
| | — |
| | (4 | ) | | 517 |
|
Other noncurrent liabilities | 581 |
| | — |
| | 1 |
| | 582 |
|
Retained earnings | 24,395 |
| | 42 |
| | 50 |
| | 24,487 |
|
As a result of the adoption of ASC 606, the opening balances as of August 31, 2018 for receivables, other current assets, and other current liabilities increased due to the reclassification of allowances for rebates, pricing adjustments, and returns to conform to the new presentation requirements. In addition, the margin from previously deferred sales to distributors was reclassified from other current liabilities to retained earnings. The tax effects of the adoption of ASC 606 were recorded primarily as a reduction of net deferred tax assets, substantially as a result of recognizing income for accounting purposes earlier under ASC 606 than for tax purposes in various jurisdictions.
The effects of ASC 606 to our consolidated statement of operations and balance sheet were as follows:
|
| | | | | | | | | | | | | | | | | | | | | | | |
| Quarter ended February 28, 2019 | | Six months ended February 28, 2019 |
| As Reported | | Adjustments | | Amounts Without the Effects of Adoption of ASC 606 | | As Reported | | Adjustments | | Amounts Without the Effects of Adoption of ASC 606 |
Revenue | $ | 5,835 |
| | $ | (20 | ) | | $ | 5,815 |
| | $ | 13,748 |
| | $ | (115 | ) | | $ | 13,633 |
|
Cost of goods sold | 2,971 |
| | (28 | ) | | 2,943 |
| | 6,269 |
| | (69 | ) | | 6,200 |
|
Interest expense | (27 | ) | | 1 |
| | (26 | ) | | (60 | ) | | 3 |
| | (57 | ) |
Income tax provision | (280 | ) | | (8 | ) | | (288 | ) | | (757 | ) | | (5 | ) | | (762 | ) |
Net income attributable to Micron | 1,619 |
| | 1 |
| | 1,620 |
| | 4,912 |
| | (48 | ) | | 4,864 |
|
|
| | | | | | | | | | | | |
As of February 28, 2019 | | As Reported | | Adjustments | | Amounts Without the Effects of Adoption of ASC 606 |
Receivables | | $ | 4,416 |
| | $ | (154 | ) | | $ | 4,262 |
|
Other current assets | | 211 |
| | (39 | ) | | 172 |
|
Deferred tax assets | | 762 |
| | 87 |
| | 849 |
|
Accounts payable and accrued expenses | | 4,062 |
| | — |
| | 4,062 |
|
Other current liabilities | | 665 |
| | (7 | ) | | 658 |
|
Other noncurrent liabilities | | 993 |
| | (1 | ) | | 992 |
|
Retained earnings | | 29,364 |
| | (98 | ) | | 29,266 |
|
Recently Issued Accounting Standards Not Yet Adopted
In November 2018, the FASB issued ASU 2018-18 – Collaborative Arrangements, which clarifies that certain transactions between collaborative arrangement participants should be accounted for as revenue when the collaborative arrangement participant is a customer in the context of a unit of account and precludes recognizing as revenue consideration received from a collaborative arrangement participant if the participant is not a customer. This ASU will be effective for us in the first quarter of 2021 with early adoption permitted. This ASU requires retrospective adoption to the date we adopted ASC 606, August 31, 2018, by recognizing a cumulative-effect adjustment to the opening balance of retained earnings of the earliest annual period presented. We are evaluating the timing and effects of our adoption of this ASU on our financial statements.
In June 2016, the FASB issued ASU 2016-13 – Measurement of Credit Losses on Financial Instruments, which requires a financial asset (or a group of financial assets) measured on the basis of amortized cost to be presented at the net amount expected to be collected. This ASU requires that the income statement reflect the measurement of credit losses for newly recognized financial assets as well as the increases or decreases of expected credit losses that have taken place during the period. This ASU requires that credit losses of debt securities designated as available-for-sale be recorded through an allowance for credit losses and limits the credit loss to the amount by which fair value is below amortized cost. This ASU will be effective for us in the first quarter of 2021 with adoption permitted as early as the first quarter of 2020. This ASU requires modified retrospective adoption, with prospective adoption for debt securities for which an other-than-temporary impairment had been recognized before the effective date. We are evaluating the timing and effects of our adoption of this ASU on our financial statements.
In February 2016, the FASB issued ASU 2016-02 – Leases, which amends a number of aspects of lease accounting, including requiring lessees to recognize operating leases with a term greater than one year on their balance sheet as a right-of- use asset and corresponding liability, measured at the present value of lease payments. This ASU, as amended, will be effective for us in the first quarter of 2020 with early adoption permitted and allows for either a modified retrospective adoption or a retrospective adoption by recognizing a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. The adoption of this ASU will result in an increase to our consolidated balance sheets for these right-of-use assets
and corresponding liabilities. We are evaluating the timing and other effects of our adoption of this ASU on our financial statements.
Cash and Investments
Cash and equivalents and the fair values of our available-for-sale investments, which approximated amortized costs, were as follows:
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
As of | | February 28, 2019 | | August 30, 2018 |
| | Cash and Equivalents | | Short-term Investments | | Long-term Marketable Investments(1) | | Total Fair Value | | Cash and Equivalents | | Short-term Investments | | Long-term Marketable Investments(1) | | Total Fair Value |
Cash | | $ | 2,652 |
| | $ | — |
| | $ | — |
| | $ | 2,652 |
| | $ | 3,223 |
| | $ | — |
| | $ | — |
| | $ | 3,223 |
|
Level 1(2) | | | | | | | | | | | | | | | | |
Money market funds | | 3,114 |
| | — |
| | — |
| | 3,114 |
| | 2,443 |
| | — |
| | — |
| | 2,443 |
|
Level 2(3) | | | | | | | | | | | | | | | | |
Corporate bonds | | 21 |
| | 692 |
| | 923 |
| | 1,636 |
| | 3 |
| | 172 |
| | 272 |
| | 447 |
|
Government securities | | 80 |
| | 255 |
| | 280 |
| | 615 |
| | 5 |
| | 63 |
| | 103 |
| | 171 |
|
Asset-backed securities | | — |
| | 105 |
| | 401 |
| | 506 |
| | — |
| | 34 |
| | 96 |
| | 130 |
|
Certificates of deposit | | 382 |
| | 39 |
| | 10 |
| | 431 |
| | 806 |
| | 11 |
| | 2 |
| | 819 |
|
Commercial paper | | 104 |
| | 89 |
| | — |
| | 193 |
| | 26 |
| | 16 |
| | — |
| | 42 |
|
| | 6,353 |
| | $ | 1,180 |
| | $ | 1,614 |
| | $ | 9,147 |
| | 6,506 |
| | $ | 296 |
| | $ | 473 |
| | $ | 7,275 |
|
Restricted cash(4) | | 76 |
| | | | | | | | 81 |
| | | | | | |
Cash, cash equivalents, and restricted cash | | $ | 6,429 |
| | | | | | | | $ | 6,587 |
| | | | | | |
| |
(1) | The maturities of long-term marketable securities range from one to four years. |
| |
(2) | The fair value of Level 1 securities is measured based on quoted prices in active markets for identical assets. |
| |
(3) | The fair value of Level 2 securities is measured using information obtained from pricing services, which obtain quoted market prices for similar instruments, non-binding market consensus prices that are corroborated by observable market data, or various other methodologies, to determine the appropriate value at the measurement date. We perform supplemental analyses to validate information obtained from these pricing services. No adjustments were made to the fair values indicated by such pricing information as of February 28, 2019 or August 30, 2018. |
| |
(4) | Restricted cash is included in other noncurrent assets and primarily consisted of balances related to the MMJ Creditor Payments. The restrictions on the MMJ Creditor Payments lapse upon approval by the trustees and/or Tokyo District Court. |
Gross realized gains and losses from sales of available-for-sale securities were not material for any period presented. As of February 28, 2019, there were no available-for-sale securities that had been in a loss position for longer than 12 months.
Receivables
|
| | | | | | | | |
As of | | February 28, 2019 | | August 30, 2018 |
Trade receivables | | $ | 3,997 |
| | $ | 5,056 |
|
Income and other taxes | | 250 |
| | 161 |
|
Other | | 169 |
| | 261 |
|
| | $ | 4,416 |
| | $ | 5,478 |
|
Inventories
|
| | | | | | | | |
As of | | February 28, 2019 | | August 30, 2018 |
Finished goods | | $ | 843 |
| | $ | 815 |
|
Work in process | | 3,023 |
| | 2,357 |
|
Raw materials and supplies | | 524 |
| | 423 |
|
| | $ | 4,390 |
| | $ | 3,595 |
|
Property, Plant, and Equipment
|
| | | | | | | | |
As of | | February 28, 2019 | | August 30, 2018 |
Land | | $ | 346 |
| | $ | 345 |
|
Buildings | | 9,547 |
| | 8,680 |
|
Equipment(1) | | 41,377 |
| | 38,249 |
|
Construction in progress(2) | | 1,715 |
| | 1,162 |
|
Software | | 745 |
| | 655 |
|
| | 53,730 |
| | 49,091 |
|
Accumulated depreciation | | (27,526 | ) | | (25,419 | ) |
| | $ | 26,204 |
| | $ | 23,672 |
|
| |
(1) | Included costs related to equipment not placed into service of $2.51 billion and $1.73 billion, as of February 28, 2019 and August 30, 2018, respectively. |
| |
(2) | Included building-related construction, tool installation, and software costs for assets not yet placed into service. |
Intangible Assets and Goodwill
|
| | | | | | | | | | | | | | | | |
As of | | February 28, 2019 | | August 30, 2018 |
| | Gross Amount | | Accumulated Amortization | | Gross Amount | | Accumulated Amortization |
Amortizing assets | | | | | | | | |
Product and process technology | | $ | 577 |
| | $ | (227 | ) | | $ | 567 |
| | $ | (344 | ) |
Non-amortizing assets | | | | | | | | |
In-process R&D | | — |
| | — |
| | 108 |
| | — |
|
| | | | | | | | |
Total intangible assets | | $ | 577 |
| | $ | (227 | ) | | $ | 675 |
| | $ | (344 | ) |
| | | | | | | | |
Goodwill | | $ | 1,228 |
| | | | $ | 1,228 |
| | |
In the first six months of 2019 and 2018, we capitalized $64 million and $15 million, respectively, for product and process technology with weighted-average useful lives of 8 years and 12 years, respectively, and placed in service $108 million of in-process R&D in the first quarter of 2019, which is being amortized on a straight-line basis over six years. Expected amortization expense is $36 million for the remainder of 2019, $66 million for 2020, $60 million for 2021, $47 million for 2022, and $43 million for 2023.
Accounts Payable and Accrued Expenses
|
| | | | | | | | |
As of | | February 28, 2019 | | August 30, 2018 |
Accounts payable | | $ | 1,523 |
| | $ | 1,692 |
|
Property, plant, and equipment payables | | 1,416 |
| | 1,238 |
|
Salaries, wages, and benefits | | 468 |
| | 841 |
|
Income and other taxes | | 449 |
| | 402 |
|
Other | | 206 |
| | 201 |
|
| | $ | 4,062 |
| | $ | 4,374 |
|
Debt
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
As of | | February 28, 2019 | | August 30, 2018 |
| | | | | | Net Carrying Amount | | Net Carrying Amount |
Instrument | | Stated Rate | | Effective Rate | | Current | | Long-Term | | Total | | Current | | Long-Term | | Total |
IMFT Member Debt(1) | | N/A |
| | N/A |
| | $ | 1,009 |
| | $ | — |
| | $ | 1,009 |
| | $ | — |
| | $ | 1,009 |
| | $ | 1,009 |
|
Capital lease obligations | | N/A |
| | 4.12 | % | | 261 |
| | 455 |
| | 716 |
| | 310 |
| | 536 |
| | 846 |
|
MMJ Creditor Payments | | N/A |
| | 9.76 | % | | 181 |
| | — |
| | 181 |
| | 309 |
| | 183 |
| | 492 |
|
2022 Term Loan B | | 4.25 | % | | 4.66 | % | | 5 |
| | 718 |
| | 723 |
| | 5 |
| | 720 |
| | 725 |
|
2024 Notes | | 4.64 | % | | 4.76 | % | | — |
| | 597 |
| | 597 |
| | — |
| | — |
| | — |
|
2025 Notes | | 5.50 | % | | 5.56 | % | | — |
| | 516 |
| | 516 |
| | — |
| | 515 |
| | 515 |
|
2026 Notes | | 4.98 | % | | 5.07 | % | | — |
| | 497 |
| | 497 |
| | — |
| | — |
| | — |
|
2029 Notes | | 5.33 | % | | 5.40 | % | | — |
| | 696 |
| | 696 |
| | — |
| | — |
| | — |
|
2032D Notes | | 3.13 | % | | 6.33 | % | | — |
| | 125 |
| | 125 |
| | — |
| | 132 |
| | 132 |
|
2033F Notes | | 2.13 | % | | 4.93 | % | | 68 |
| | — |
| | 68 |
| | 235 |
| | — |
| | 235 |
|
2043G Notes | | 3.00 | % | | 6.76 | % | | 1,110 |
| | — |
| | 1,110 |
| | — |
| | 682 |
| | 682 |
|
| | | | | | $ | 2,634 |
| | $ | 3,604 |
| | $ | 6,238 |
| | $ | 859 |
| | $ | 3,777 |
| | $ | 4,636 |
|
| |
(1) | IMFT Member Debt was classified as current as of February 28, 2019 as a result of exercising our option to acquire Intel's interest in IMFT. |
Senior Unsecured Notes
On February 6, 2019, we issued our 2024 Notes, 2026 Notes, and 2029 Notes in a public offering. Issuance costs for these notes were $11 million. We may redeem some or all of these notes at our option prior to their maturity at a redemption price equal to accrued interest plus the present value of the remaining scheduled payments and we may redeem some or all of these notes at par between one and three months prior to maturity.
Each of the 2024 Notes, 2026 Notes, and 2029 Notes contain covenants that, among other things, limit, in certain circumstances, our ability and/or the ability of our restricted subsidiaries (which are generally domestic subsidiaries in which we own at least 80% of the voting stock) to (1) create or incur certain liens, (2) enter into certain sale and lease-back transactions; and (3) consolidate with or merge with or into, or convey, transfer or lease all or substantially all of our assets, to another entity. These covenants are subject to a number of limitations and exceptions. Additionally, if a change in control triggering event occurs, as defined in the indenture governing such notes, we will be required to offer to purchase such notes at 101% of the outstanding aggregate principal amount plus accrued interest up to the purchase date.
Convertible Senior Notes
On February 8, 2019, we notified holders of our 2043G Notes that we would redeem all of the outstanding 2043G Notes on March 13, 2019. Holders could elect to convert these notes prior to March 12, 2019 at a conversion rate of 34.2936 shares of our common stock per $1,000 of principal amount. In connection with our notice, we made an irrevocable election to settle any
conversions in cash. As a result, we reclassified $336 million from equity to a derivative debt liability. As of February 28, 2019, current debt included an aggregate of $1.11 billion for the settlement obligation (including principal and amounts in excess of principal) of all of our 2043G Notes. Holders converted substantially all of the 2043G Notes and on March 13, 2019, we paid $1.43 billion to settle the conversions and recognized a loss of $316 million in the third quarter of 2019.
Holders of our convertible notes may convert their notes during any calendar quarter if the closing price of our common stock for at least 20 trading days in the 30 consecutive trading days ending on the last trading day of the preceding calendar quarter is more than 130% of the conversion price. As of February 28, 2019, the trading price of our common stock was higher than the initial conversion prices of our 2032D Notes and our 2033F Notes and, as a result, the aggregate conversion value of $807 million exceeded the aggregate principal amount of $203 million by $604 million.
Available Revolving Credit Facility
On November 27, 2018, we increased the amount available to draw under our existing revolving credit facility expiring in July 2023 from $2.0 billion to $2.5 billion. As of February 28, 2019, there were no outstanding amounts drawn under this facility.
Debt Activity
When we receive a notice of conversion for any of our convertible notes and elect to settle in cash any portion of the conversion obligation in excess of the principal amount, the cash settlement obligations become derivative debt liabilities subject to mark-to-market accounting treatment based on the volume-weighted-average price of our common stock over a period of 20 consecutive trading days. Accordingly, at the date of our election to settle a conversion in cash, we reclassify the fair value of the equity component of the converted notes from additional capital to derivative debt liability within current debt in our consolidated balance sheet.
The following table presents the effects of conversions, settlements, and issuance of debt in the first six months of 2019:
|
| | | | | | | | | | | | | | | | | | | | |
Six months ended February 28, 2019 | | Increase (Decrease) in Principal | | Increase (Decrease) in Carrying Value | | Increase (Decrease) in Cash | | Decrease in Equity | | Gain (Loss) |
Settled conversions | | | | | | | | | | |
2032D Notes | | $ | (10 | ) | | $ | (9 | ) | | $ | (35 | ) | | $ | (28 | ) | | $ | 2 |
|
2033F Notes | | (38 | ) | | (169 | ) | | (164 | ) | | (8 | ) | | 13 |
|
Conversions not settled | | | | | | | | | | |
2043G Notes | | — |
| | 420 |
| | — |
| | (336 | ) | | (84 | ) |
Issuances | | | | | | | | | | |
2024 Notes | | 600 |
| | 597 |
| | 597 |
| | — |
| | — |
|
2026 Notes | | 500 |
| | 497 |
| | 497 |
| | — |
| | — |
|
2029 Notes | | 700 |
| | 695 |
| | 695 |
| | — |
| | — |
|
| | $ | 1,752 |
| | $ | 2,031 |
| | $ | 1,590 |
| | $ | (372 | ) | | $ | (69 | ) |
Contingencies
We have accrued a liability and charged operations for the estimated costs of adjudication or settlement of various asserted and unasserted claims existing as of the balance sheet date, including those described below. We are currently a party to other legal actions arising from the normal course of business, none of which is expected to have a material adverse effect on our business, results of operations, or financial condition.
Patent Matters
As is typical in the semiconductor and other high-tech industries, from time to time, others have asserted, and may in the future assert, that our products or manufacturing processes infringe upon their intellectual property rights.
On November 21, 2014, Elm 3DS Innovations, LLC ("Elm") filed a patent infringement action against Micron; Micron Semiconductor Products, Inc.; and Micron Consumer Products Group, Inc. in the U.S. District Court for the District of Delaware. On March 27, 2015, Elm filed an amended complaint against the same entities. The amended complaint alleges that unspecified semiconductor products of ours that incorporate multiple stacked die infringe 13 U.S. patents and seeks damages, attorneys' fees, and costs.
On December 15, 2014, Innovative Memory Solutions, Inc. ("IMS") filed a patent infringement action against Micron in the U.S. District Court for the District of Delaware. The complaint alleges that a variety of our NAND products infringe eight U.S. patents and seeks damages, attorneys' fees, and costs. On July 23, 2018, IMS served a patent infringement complaint on Micron Semiconductor (Deutschland) GmbH and Micron Europe Limited alleging that products including our SSDs infringe a European patent. The complaint seeks unspecified damages and an order forbidding Micron Semiconductor (Deutschland) GmbH and Micron Europe Limited from offering to sell, using, and importing the accused products. On August 31, 2018, Micron was served with a complaint filed by IMS in Shenzhen Intermediate People's Court in Guangdong Province, China. The complaint alleges that certain of our NAND flash products infringe a Chinese patent. The complaint seeks an order requiring Micron to stop manufacturing, using, selling, and offering for sale the accused products in China, and to pay damages of 1 million Chinese yuan plus expenses.
On March 19, 2018, Micron Semiconductor (Xi’an) Co., Ltd. ("MXA") was served with a patent infringement complaint filed by Fujian Jinhua Integrated Circuit Co., Ltd. ("Jinhua") in the Fuzhou Intermediate People’s Court in Fujian Province, China (the "Fuzhou Court"). On April 3, 2018, Micron Semiconductor (Shanghai) Co. Ltd. ("MSS") was served with the same complaint. The complaint alleges that MXA and MSS infringe a Chinese patent by manufacturing and selling certain Crucial DDR4 DRAM modules. The complaint seeks an order requiring MXA and MSS to destroy inventory of the accused products and equipment for manufacturing the accused products in China, to stop manufacturing, using, selling, and offering for sale the accused products in China, and to pay damages of 98 million Chinese yuan plus court fees incurred.
On March 21, 2018, MXA was served with a patent infringement complaint filed by United Microelectronics Corporation ("UMC") in the Fuzhou Court. On April 3, 2018, MSS was served with the same complaint. The complaint alleges that MXA and MSS infringe a Chinese patent by manufacturing and selling certain Crucial DDR4 DRAM modules. The complaint seeks an order requiring MXA and MSS to destroy inventory of the accused products and equipment for manufacturing the accused products in China, to stop manufacturing, using, selling, and offering for sale the accused products in China, and to pay damages of 90 million Chinese yuan plus court fees incurred.
On April 3, 2018, MSS was served with another patent infringement complaint filed by Jinhua and two additional complaints filed by UMC in the Fuzhou Court. The three additional complaints allege that MSS infringes three Chinese patents by manufacturing and selling certain Crucial MX300 SSDs and certain GDDR5 memory chips. The two complaints filed by UMC each seek an order requiring MSS to destroy inventory of the accused products and equipment for manufacturing the accused products in China, to stop manufacturing, using, selling, and offering for sale the accused products in China, and to pay damages of 90 million Chinese yuan plus court fees incurred. The complaint filed by Jinhua seeks an order requiring MSS to destroy inventory of the accused products and equipment for manufacturing the accused products in China, to stop manufacturing, using, selling, and offering for sale the accused products in China, and to pay damages of 98 million Chinese yuan plus court fees incurred. On October 9, 2018, UMC withdrew its complaint that alleged MSS infringed a Chinese patent by manufacturing and selling certain GDDR5 memory chips.
On July 5, 2018, MXA and MSS were notified that the Fuzhou Court granted a preliminary injunction against those entities that enjoins them from manufacturing, selling, or importing certain Crucial and Ballistic-branded DRAM modules and solid-state drives in China. The affected products make up slightly more than 1% of our annualized revenues. We are complying with the ruling and have requested the Fuzhou Court to reconsider or stay its decision.
Among other things, the above lawsuits pertain to substantially all of our DRAM, NAND, and other memory and storage products we manufacture, which account for a significant portion of our revenue.
Qimonda
On January 20, 2011, Dr. Michael Jaffé, administrator for Qimonda's insolvency proceedings, filed suit against Micron and Micron Semiconductor B.V., our Netherlands subsidiary ("Micron B.V."), in the District Court of Munich, Civil Chamber. The complaint seeks to void, under Section 133 of the German Insolvency Act, a share purchase agreement between Micron B.V. and Qimonda signed in fall 2008, pursuant to which Micron B.V. purchased substantially all of Qimonda's shares of Inotera (the "Inotera Shares"), representing approximately 18% of Inotera's outstanding shares as of February 28, 2019, and seeks an order
requiring us to re-transfer those shares to the Qimonda estate. The complaint also seeks, among other things, to recover damages for the alleged value of the joint venture relationship with Inotera and to terminate, under Sections 103 or 133 of the German Insolvency Code, a patent cross-license between us and Qimonda entered into at the same time as the share purchase agreement.
Following a series of hearings with pleadings, arguments, and witnesses on behalf of the Qimonda estate, on March 13, 2014, the court issued judgments: (1) ordering Micron B.V. to pay approximately $1 million in respect of certain Inotera Shares sold in connection with the original share purchase; (2) ordering Micron B.V. to disclose certain information with respect to any Inotera Shares sold by it to third parties; (3) ordering Micron B.V. to disclose the benefits derived by it from ownership of the Inotera Shares, including in particular, any profits distributed on the Inotera Shares and all other benefits; (4) denying Qimonda's claims against Micron for any damages relating to the joint venture relationship with Inotera; and (5) determining that Qimonda's obligations under the patent cross-license agreement are canceled. In addition, the court issued interlocutory judgments ordering, among other things: (1) that Micron B.V. transfer to the Qimonda estate the Inotera Shares still owned by Micron B.V. and pay to the Qimonda estate compensation in an amount to be specified for any Inotera Shares sold to third parties; and (2) that Micron B.V. pay the Qimonda estate as compensation an amount to be specified for benefits derived by Micron B.V. from ownership of the Inotera Shares. The interlocutory judgments have no immediate, enforceable effect on us, and, accordingly, we expect to be able to continue to operate with full control of the Inotera Shares subject to further developments in the case. We have filed a notice of appeal, and the parties have submitted briefs to the appeals court.
Antitrust Matters
On April 27, 2018, a complaint was filed against Micron and other DRAM suppliers in the U.S. District Court for the Northern District of California. Subsequently two substantially identical cases were filed in the same court. The lawsuits purport to be on behalf of a nationwide class of indirect purchasers of DRAM products. The complaints assert claims based on alleged price-fixing of DRAM products under federal and state law during the period from June 1, 2016 to February 1, 2018, and seek treble monetary damages, costs, interest, attorneys' fees, and other injunctive and equitable relief.
On June 26, 2018, a complaint was filed against Micron and other DRAM suppliers in the U.S. District Court for the Northern District of California. Subsequently four substantially identical cases were filed in the same court. The lawsuits purport to be on behalf of a nationwide class of direct purchasers of DRAM products. The complaints assert claims based on alleged price-fixing of DRAM products under federal and state law during the period from June 1, 2016 to February 1, 2018, and seek treble monetary damages, costs, interest, attorneys' fees, and other injunctive and equitable relief.
Additionally, six cases have been filed in the following Canadian courts: Superior Court of Quebec, the Federal Court of Canada, and the Supreme Court of British Columbia. The substantive allegations in these cases are similar to those asserted in the cases filed in the United States.
On May 15, 2018, the Chinese State Administration for Market Regulation ("SAMR") notified Micron that it was investigating potential collusion and other anticompetitive conduct by DRAM suppliers in China. On May 31, 2018, SAMR made unannounced visits to our sales offices in Beijing, Shanghai, and Shenzhen to seek certain information as part of its investigation. We are cooperating with SAMR in its investigation.
Securities Matters
On January 23, 2019, a complaint was filed against Micron and two of our officers, Sanjay Mehrotra and David Zinsner, in the U.S. District Court for the Southern District of New York. The lawsuit purports to be brought on behalf of a class of purchasers of our stock during the period from June 22, 2018 through November 19, 2018. Subsequently two substantially similar cases were filed in the same court adding one of our former officers, Ernie Maddock, as a defendant and alleging a class action period from September 26, 2017 through November 19, 2018. The three complaints allege that defendants committed securities fraud through misrepresentations and omissions about purported anticompetitive behavior in the DRAM industry and seek compensatory and punitive damages, fees, interest, costs, and other appropriate relief.
On March 5, 2019, a shareholder derivative complaint was filed in the U.S. District Court for the District of Delaware, allegedly on behalf of and for the benefit of Micron, against certain current and former officers and directors of Micron for alleged breaches of their fiduciary duties and other violations of law. The allegations are based on, among other things, purported false and misleading statements regarding anticompetitive behavior in the DRAM industry. The complaint seeks damages, fees, interest, costs, and other appropriate relief.
Other
On December 5, 2017, Micron filed a complaint against UMC and Jinhua in the U.S. District Court for the Northern District of California. The complaint alleges that UMC and Jinhua violated the Defend Trade Secrets Act, the civil provisions of the Racketeer Influenced and Corrupt Organizations Act, and California's Uniform Trade Secrets Act by misappropriating Micron's trade secrets and other misconduct. Micron's complaint seeks damages, restitution, disgorgement of profits, injunctive relief, and other appropriate relief.
In the normal course of business, we are a party to a variety of agreements pursuant to which we may be obligated to indemnify the other party. It is not possible to predict the maximum potential amount of future payments under these types of agreements due to the conditional nature of our obligations and the unique facts and circumstances involved in each particular agreement. Historically, our payments under these types of agreements have not had a material adverse effect on our business, results of operations, or financial condition.
We are unable to predict the outcome of the patent matters, the Qimonda matter, antitrust matters, securities matters, and other matters noted above and therefore cannot estimate the range of possible loss. A determination that our products or manufacturing processes infringe the intellectual property rights of others or entering into a license agreement covering such intellectual property could result in significant liability and/or require us to make material changes to our products and/or manufacturing processes. Any of the foregoing, as well as the resolution of any other legal matter noted above, could have a material adverse effect on our business, results of operations, or financial condition.
Equity
Micron Shareholders' Equity
Common Stock Repurchases: Our Board of Directors has authorized the discretionary repurchase of up to $10 billion of our outstanding common stock beginning in our fiscal 2019. We may purchase shares on a discretionary basis through open-market purchases, block trades, privately-negotiated transactions, derivative transactions, and/or pursuant to Rule 10b5-1 trading plans, subject to market conditions and our ongoing determination of the best use of available cash. The repurchase authorization does not obligate us to acquire any common stock.
In the second quarter and first six months of 2019, we repurchased 21 million shares of our common stock for $702 million and 63 million shares of our common stock for $2.51 billion, respectively, under an accelerated share repurchase agreement, Rule 10b5-1 plans, and through open market repurchases. The shares were recorded as treasury stock.
Noncontrolling Interests in Subsidiaries
|
| | | | | | | | | | | | | | |
As of | | February 28, 2019 | | August 30, 2018 |
| | Balance | | Percentage | | Balance | | Percentage |
IMFT | | $ | 858 |
| | 49 | % | | $ | 853 |
| | 49 | % |
Other | | 5 |
| | Various |
| | 17 |
| | Various |
|
| | $ | 863 |
| | | | $ | 870 |
| | |
IMFT: Since 2006, we have owned 51% of IMFT, a joint venture between us and Intel. IMFT is governed by a Board of Managers, for which the number of managers appointed by each member varies based on the members' respective ownership interests. IMFT manufactures semiconductor products exclusively for its members under a long-term supply agreement at prices approximating cost. In the first quarter of 2018, IMFT discontinued production of NAND and subsequent to that time has manufactured 3D XPoint memory. Through our IMFT joint venture, we continue to jointly develop 3D XPoint technologies with Intel through the second generation of 3D XPoint technology, which is expected to be completed in the second half of 2019. To better optimize the 3D XPoint technology for our product roadmap and maximize the benefits for our customers and shareholders, in the fourth quarter of 2018, we announced that we will no longer jointly develop with Intel subsequent generations of 3D XPoint technology. IMFT will continue to manufacture memory based on 3D XPoint technology at the fabrication facility in Lehi, Utah for its members. IMFT sales to Intel were $172 million and $347 million for the second quarter and first six months of 2019, respectively, and were $115 million and $227 million for the second quarter and first six months of 2018, respectively.
On January 14, 2019, we exercised our option to acquire Intel's interest in IMFT. As a result, Intel can elect to set the closing date of the transaction to be any time between approximately six months to one year from the date we exercised our call option. At the time of closing, we expect to pay Intel consideration approximating Intel's interest in the net book value of IMFT plus member debt. Following the closing date, we will continue to supply to Intel product from IMFT for a period of up to one year under a fixed-price arrangement for the duration of the supply agreement. The pricing will be determined at the time of the closing of our acquisition of Intel's interest based on the cost of products produced by IMFT over a period of time prior to closing, plus a margin. For the first six months of such one-year period, Intel can receive supply ranging from 50% to 100%, at Intel's choice, of the volume supplied to Intel by IMFT in the six-month period immediately prior to the closing date. For the second six months of such one-year period, Intel can receive supply ranging from 0% to 100%, at Intel's choice, of the volume supplied to Intel by IMFT in the first six-month period.
IMFT's capital requirements are generally determined based on an annual plan approved by the members, and capital contributions to IMFT are requested as needed. Capital requests are made to the members in proportion to their then-current ownership interest. Members may elect to not contribute their proportional share, and in such event, the contributing member may elect to contribute any amount of the capital request, either in the form of an equity contribution or member debt financing. Under the supply agreement, the members have rights and obligations to the capacity of IMFT in proportion to their investment, including member debt financing. Any capital contribution or member debt financing results in a proportionate adjustment to the sharing of output on an eight-month lag. Members pay their proportionate share of fixed costs associated with IMFT's capacity.
Creditors of IMFT have recourse only to IMFT's assets and do not have recourse to any other of our assets. The following table presents the assets and liabilities of IMFT included in our consolidated balance sheets:
|
| | | | | | | | |
As of | | February 28, 2019 | | August 30, 2018 |
Assets | | | | |
Cash and equivalents | | $ | 288 |
| | $ | 91 |
|
Receivables | | 126 |
| | 126 |
|
Inventories | | 111 |
| | 114 |
|
Other current assets | | 5 |
| | 8 |
|
Total current assets | | 530 |
| | 339 |
|
Property, plant, and equipment | | 2,464 |
| | 2,641 |
|
Other noncurrent assets | | 36 |
| | 45 |
|
Total assets | | $ | 3,030 |
| | $ | 3,025 |
|
| | | | |
Liabilities | | |
| | |
|
Accounts payable and accrued expenses | | $ | 154 |
| | $ | 138 |
|
Current debt | | 1,020 |
| | 20 |
|
Other current liabilities | | 37 |
| | 9 |
|
Total current liabilities | | 1,211 |
| | 167 |
|
Long-term debt | | 54 |
| | 1,064 |
|
Other noncurrent liabilities | | 37 |
| | 74 |
|
Total liabilities | | $ | 1,302 |
| | $ | 1,305 |
|
Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets.
Fair Value Measurements
All of our marketable debt and equity investments were classified as available-for-sale and carried at fair value as of the dates noted below. The estimated fair values of our convertible and other notes in the table below were determined based on Level 2 inputs, and together with the carrying value of our outstanding debt instruments (excluding the carrying value of equity and mezzanine equity components of our convertible notes) were as follows:
|
| | | | | | | | | | | | | | | | |
As of | | February 28, 2019 | | August 30, 2018 |
| | Fair Value | | Carrying Value | | Fair Value | | Carrying Value |
Notes and MMJ Creditor Payments | | $ | 4,291 |
| | $ | 4,219 |
| | $ | 2,798 |
| | $ | 2,741 |
|
Convertible notes | | 2,232 |
| | 1,303 |
| | 3,124 |
| | 1,049 |
|
Other operating (income) expense, net included unrealized losses from assets held for sale of $46 million in the second quarter of 2019. The fair values for semiconductor equipment were based on quotations obtained from equipment dealers, which consider the remaining useful life and configuration of the equipment (Level 3).
Derivative Instruments
|
| | | | | | | | | | | | |
| | Gross Notional Amount | | Fair Value of |
Current Assets(1) | | Current Liabilities(2) |
As of February 28, 2019 | | | | | | |
Derivative instruments with hedge accounting designation | | | | | | |
Cash flow currency hedges | | $ | 235 |
| | $ | — |
| | $ | (3 | ) |
| | | | | | |
Derivative instruments without hedge accounting designation | | | | | | |
Non-designated currency hedges | | 2,205 |
| | |